Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Response and Resistance to Menin Inhibitor in UBTF-Tandem Duplication AML.

The New England journal of medicine - 27 Jun 2024

Tiong Ing Soo, Ritchie David S, Blombery Piers

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Benzamides
Share to Drug Resistance, Neoplasm
Share to Hematopoietic Stem Cell Transplantation
Share to Leukemia, Myeloid, Acute

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Proto-Oncogene Proteins

Share to Recurrence

Share to Spiro Compounds

Share to Treatment Outcome

Source

Identifiers

PMID: 38924737
DOI: 10.1056/NEJMc2404110

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Response and Resistance to Menin Inhibitor in UBTF-Tandem Duplication AML.PMID 38924737Read ↗

Menin inhibitors in KMT2A-rearranged leukemia: Mechanistic insights, clinical trial progress, and potential of combination therapiesSemantic proximity Read ↗

Common Driver Mutations in AML: Biological Impact, Clinical Considerations, and Treatment Strategies.Semantic proximity Read ↗

Menin inhibitors in the treatment of acute myeloid leukemiaSemantic proximity Read ↗

MLL-menin and FLT3 inhibitors team up for AML.Semantic proximity Read ↗

Upfront Menin-inhibitor resistance in multiply pretreated leukemiasSemantic proximity Read ↗

Menin inhibitors for the treatment of acute myeloid leukemia: challenges and opportunities ahead.Semantic proximity Read ↗

Combination Strategies with Menin Inhibitors for Acute LeukemiaSemantic proximity Read ↗

Menin Inhibitors: A New Era of Targeted Therapies in Acute Myeloid Leukemia.Semantic proximity Read ↗

Hitting the target in IDH2 mutant AML.Semantic proximity Read ↗

Targeting IDH: the next big thing in AML.Semantic proximity Read ↗

Genetic characterization of ABT-199 sensitivity in human AMLSemantic proximity Read ↗

Emerging drug profile: menin inhibitors in NPM1-mutated and KM2A-rearranged acute myeloid leukemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.